Second messenger c-di-AMP regulates multiple antibiotic sensitivity pathways in Mycobacterium smegmatis by discrete mechanisms
- 9 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 371
Abstract
One of the debilitating causes of high mortality in the case of tuberculosis and other bacterial infections is the resistance development against standard drugs. There are limited studies so far to describe how a bacterial second messenger molecule can directly participate in distinctive antibiotic tolerance characteristics of a cell in a mechanism-dependent manner. Here we show that intracellular cyclic di-AMP (c-di-AMP) concentration can modulate drug sensitivity of Mycobacterium smegmatis by interacting with an effector protein or interfering with the 5’-UTR regions in mRNA of the genes and thus causing transcriptional downregulation of important genes in the pathways. We studied four antibiotics with different mechanisms of action: rifampicin, ciprofloxacin, erythromycin, and tobramycin and subsequently found that the level of drug sensitivity of the bacteria is directly proportional to the c-di-AMP concentration inside the cell. Further, we unraveled the underlying molecular mechanisms to delineate the specific genes and pathways regulated by c-di-AMP and hence result in differential drug sensitivity in M. smegmatisKeywords
Funding Information
- Department of Biotechnology, GOI (BT/RLF/Re-entry/31/2017)
- STAR (STR/2021/000015)
- Anusandhan National Research Foundation
- Swedish Research Council (2016–06264, 2018–05946, 2018–05498)
- Knut and Alice Wallenberg Foundation (KAW 2017.0055)
This publication has 55 references indexed in Scilit:
- Sub-operon promoter arrangement of disA facilitates c-di-AMP homeostasis and selective stress responses in Mycobacterium smegmatisJournal of Biosciences, 2023
- Elucidating the role of c-di-AMP in Mycobacterium smegmatis: Phenotypic characterization and functional analysisHeliyon, 2023
- Modulation of a Mycobacterial ADP-Ribosyltransferase to Augment Rifamycin Antibiotic ResistanceACS Infectious Diseases, 2021
- Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosisTuberculosis, 2016
- On the acquisition and analysis of microscale thermophoresis dataAnalytical Biochemistry, 2016
- Calculations and Publication-Quality Illustrations for Analytical Ultracentrifugation Data2015
- The Ribosomal Stalk Plays a Key Role in IF2-Mediated Association of the Ribosomal SubunitsJournal of Molecular Biology, 2010
- To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?Current Opinion in Microbiology, 2010
- Structural Biochemistry of a Bacterial Checkpoint Protein Reveals Diadenylate Cyclase Activity Regulated by DNA Recombination IntermediatesMolecular Cell, 2008
- The Ribosomal Stalk Binds to Translation Factors IF2, EF-Tu, EF-G and RF3 via a Conserved Region of the L12 C-terminal DomainJournal of Molecular Biology, 2007